Anlon Healthcare Share Price Target 2025, 2026, 2030, 2040, 2050

Anlon Healthcare is a medicine-making company situated in Rajkot, Gujarat, India. It makes important chemical ingredients that are used to produce different types of medicines like tablets, syrups, creams, and capsules. The company offers many products, including ingredients for human medicines, health supplements, personal care items, and animal medicines. It is also one of the few companies in India that makes a pain relief ingredient, Loxoprofen Sodium Dihydrate. Anlon focuses a lot on research and has a modern factory that follows strict health and safety rules from Indian and international authorities like the FDA and WHO-GMP.

What is Anlon Healthcare Ltd NSE: AHCL?

Anlon Healthcare is a company from Rajkot that makes important ingredients used in medicines and health products. They work in areas like medicines, vitamins, personal care items, and animal health products. The company creates special chemical ingredients that follow strict quality rules used worldwide. They have a modern factory and four labs where they develop and improve their products. It sells its products to more than 15 countries in Europe, South America, the Middle East, Africa, and Asia. They already have over 65 products on the market and many more being tested or developed.

Anlon Healthcare Share Price

Anlon Healthcare Share Price Target 2025

It has received approvals from health authorities in countries like Brazil, China, and Japan to sell its medicine, Loxoprofen. It has also sent applications to health departments in other countries, such as those in the European Union, Russia, Japan, South Korea, Iran, Jordan, and Pakistan, to get permission to sell its products there. The company is also planning to apply for approval to sell two more medicines, Ketoprofen in the USA and Dexketoprofen Trometamol in Spain, Italy, Germany, and Slovenia. In 2025, its share price target would be ₹227, as per our analysis.

By our prediction, its share price would be between ₹70 to ₹227 in 2025.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2025	70	227

Month	Minimum Price  (Rs)	Maximum Price (Rs)
September	70	162
October	74	188
November	85	200
December	165	227

Anlon Healthcare share price Target 2026

It makes and sells a wide range of products. It already has 65 products available in the market, 28 more are being tested in small batches, and 49 are still in the early stages of lab testing. The company is working hard to grow and bring out new medicines. Besides selling in India, it also has customers in over 15 countries around the world. These include countries like Italy, Germany, South Korea, China, Japan, the UK, the UAE, as well as Argentina, Chile, Colombia, Mexico, Egypt, Turkey, and Brazil. This shows that the company is growing globally and can meet the standards needed to sell in other countries. In 2026, its share price target would be ₹408, as per our prediction.

Its share price would be between ₹203 to ₹408 in 2026, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2026	202	408

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	202	270
February	220	289
March	216	298
April	225	300
May	237	321
June	240	332
July	247	340
August	250	347
September	262	360
October	260	378
November	288	385
December	300	408

Share price Target 2027

Its factory has two buildings dedicated to making important parts of medicines. Together, these buildings can produce a very large amount each year, showing the company can make lots of products. The factory also has four labs where workers test and check the medicines to make sure they are safe and of good quality. There are special places to store raw materials and finished products safely. The factory uses modern machines like big glass and steel reactors that can hold up to 4,000 litres, as well as equipment to filter, separate, and dry the materials. In 2027, its share price target would be ₹627, as per our analysis.

By our prediction, its share price would be between ₹380 to ₹627 in 2027.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2027	380	627

Share price Target 2028

It has special ways to test and check its products to make sure they follow the rules and meet what customers want. It works hard to keep its products safe and of good quality. The company also keeps improving how it makes products to remove unwanted parts and make them cleaner. It does extra tests in the lab to make sure the products are exactly right when making special products for customers. This shows the company cares about making high-quality products and meeting customers’ needs. In 2028, its share price target would be ₹838, as per our analysis.

By our prediction, its share price would be between ₹602 to ₹838 in 2028.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2028	602	838

Share price Target 2029

The company has an important quality certificate, ISO 9001:2015. It follows strict rules to manage its work well. It also has other certificates like GMP and GMP-WHO, which show it makes medicines safely and correctly. The company is Halal certified, so its products meet special religious requirements. It cares about the environment and uses systems to clean its wastewater so no harmful liquids are released. This shows the company cares about safety, health, and the environment. In the last few years, the company’s profit has grown steadily, going from Rs 5.82 crore to Rs 9.66 crore, and then to Rs 20.52 crore. In 2029, its share price target would be ₹1058, as per our prediction.

Its share price would be between ₹810 to ₹1058 in 2029, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2029	810	1058

Anlon Healthcare share price Target 2030

It makes two main types of products: pharmaceutical intermediates, which are the raw materials, and active pharmaceutical ingredients (APIs), which are the main parts that make medicines work. These are used in tablets, syrups, capsules, creams, and also in products for health, nutrition, skincare, and animal care. The company offers a wide range of these ingredients and follows strict quality rules from India and other countries. Anlon Healthcare also creates special chemical products based on what each customer needs, including very pure versions when required. In 2030, its share price target would be ₹1302, as per our analysis.

By our prediction, its share price would be between ₹1030 to ₹1302 in 2030.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2030	1030	1302

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	1030	1114
February	1041	1129
March	1050	1154
April	1047	1162
May	1052	1170
June	1065	1179
July	1060	1192
August	1078	1200
September	1089	1214
October	1100	1235
November	1124	1254
December	1141	1302

Share price Target 2040

It makes sure its products are safe and high-quality by doing careful testing, regular checks, and improving how things are made. The company has four labs and a trained team, many with science backgrounds, to make sure the products meet customer needs and industry rules. It offers many products, including pharmaceutical intermediates like Cyanoethylbenzoic acid, Ketonitrile, and Methyldesloratadine, which are used as key ingredients to help make the main parts of medicines. It also makes active pharmaceutical ingredients, which are the parts of medicines that help people feel better. In 2040, its share price target would be ₹3420, as per our prediction.

Its share price would be between ₹3150 to ₹3420 in 2040, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2040	3150	3420

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	3150	3265
February	3165	3285
March	3160	3300
April	3174	3317
May	3186	3332
June	3200	3357
July	3225	3374
August	3254	3390
September	3274	3412
October	3290	3457
November	3325	3478
December	3358	3520

Share Price Target 2050

It makes many different types of products, which helps it serve various parts of healthcare, like medicines for people, animals, and personal care. The company is led by experienced people who guide its growth and make smart decisions. In the pharmaceutical industry, there are many rules and strict approval steps. Because of this, it’s not easy for new companies to start quickly, which gives them an advantage. The company also does its own testing and quality checks to make sure its products are safe and reliable. It also focuses on protecting the environment and keeping its workers safe and healthy. In 2050, its share price target would be ₹7780, as per our analysis.

By our prediction, its share price would be between ₹7366 to ₹7780 in 2050.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2050	7366	7780

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	7366	7477
February	7371	7490
March	7389	7511
April	7410	7535
May	7432	7554
June	7440	7569
July	7458	7588
August	7481	7611
September	7474	7638
October	7525	7651
November	7554	7687
December	7611	7780

Should I buy Anlon Healthcare stock?

Year	Minimum Price (Rs)	Maximum Price (Rs)
2025	70	227
2026	202	408
2027	380	627
2028	602	838
2029	810	1058
2030	1030	1302
2040	3150	3420
2050	7366	7780

It has been doing well financially, making more money and growing over time. They are working on making more products, paying off their debts, and managing their money better, which can help the company grow even more. The price of their stock seems fair compared to other similar companies, and they are earning good profits. Overall, AIt could be a good choice if you’re okay with some risk and want to invest for a longer time.

Anlon Healthcare earnings results (Financials)

	Mar 2021	Mar 2023	Mar 2024
Sales +	15.98	112.81	66.39
Expenses +	21.15	100.26	50.69
Operating Profit	-5.17	12.55	15.70
OPM %	-32.35%	11.12%	23.65%
Other Income +	0.33	0.24	0.11
Interest	3.21	3.93	4.17
Depreciation	1.86	1.87	1.89
Profit before tax	-9.91	6.99	9.75
Tax %	3.33%	16.74%	0.92%
Net Profit +	-10.24	5.82	9.66
EPS in Rs	—	—	—
Dividend Payout %	0.00%	0.00%	0.00%

Is Anlon Healthcare stock good to buy? (bull case & bear case)

Bull Case:

• The company’s sales went up from ₹31.79 crore to ₹62.53 crore in two years.
• Profit increased from ₹5.82 crore to ₹20.52 crore during the same time.
• Products are sold in over 15 countries, like Japan, Brazil, and Germany.
• It holds important quality certificates like ISO 9001:2015 and GMP-WHO.
• Filed 11 official documents with global health authorities for approval.
• Shows strong return numbers: Return on Equity is 43.29%, and Return on Capital is 48.78%.
• Plans to grow its factory, reduce loans, and improve daily operations.
• Operates in the healthcare and pharma space, which is growing worldwide.

Bear Case:

• It’s a small company with a market value of around ₹240 crore, so the stock price can move up or down quickly.
• Not many people trade this stock daily, so selling it might be hard during a drop.
• Online comments warn that the stock may be hyped up without strong financial support.
• The company depends a lot on a few big customers, which is risky if they stop buying.

Conclusion

It makes ingredients used in medicines and health products. It follows strict safety and quality rules and sells its products in many countries. The company is growing and making more products, and its profits are also increasing. But, it still has some money problems, like getting payments late from customers and managing daily costs. Even with these issues, the company is improving and could do well over time.

FAQs